10-84194816-G-A
Variant summary
Our verdict is Pathogenic. Variant got 14 ACMG points: 14P and 0B. PVS1_StrongPM2PP5_Very_Strong
The NM_033100.4(CDHR1):c.55+1G>A variant causes a splice donor, intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000685 in 1,532,974 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. 3/3 splice prediction tools predicting alterations to normal splicing. Variant has been reported in ClinVar as Likely pathogenic (★★).
Frequency
Consequence
NM_033100.4 splice_donor, intron
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 14 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CDHR1 | NM_033100.4 | c.55+1G>A | splice_donor_variant, intron_variant | ENST00000623527.4 | NP_149091.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CDHR1 | ENST00000623527.4 | c.55+1G>A | splice_donor_variant, intron_variant | 1 | NM_033100.4 | ENSP00000485478.1 | ||||
CDHR1 | ENST00000332904.7 | c.55+1G>A | splice_donor_variant, intron_variant | 1 | ENSP00000331063.3 |
Frequencies
GnomAD3 genomes AF: 0.000335 AC: 51AN: 152180Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000698 AC: 9AN: 128922Hom.: 0 AF XY: 0.0000852 AC XY: 6AN XY: 70386
GnomAD4 exome AF: 0.0000384 AC: 53AN: 1380678Hom.: 0 Cov.: 32 AF XY: 0.0000455 AC XY: 31AN XY: 681378
GnomAD4 genome AF: 0.000341 AC: 52AN: 152296Hom.: 0 Cov.: 33 AF XY: 0.000376 AC XY: 28AN XY: 74456
ClinVar
Submissions by phenotype
not provided Pathogenic:1
Likely pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Feb 02, 2025 | This sequence change affects a donor splice site in intron 1 of the CDHR1 gene. It is expected to disrupt RNA splicing. Variants that disrupt the donor or acceptor splice site typically lead to a loss of protein function (PMID: 16199547), and loss-of-function variants in CDHR1 are known to be pathogenic (PMID: 23044944, 23591405, 26103963, 26261414). This variant is present in population databases (rs547198427, gnomAD 0.1%). This variant has not been reported in the literature in individuals affected with CDHR1-related conditions. ClinVar contains an entry for this variant (Variation ID: 866140). Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may disrupt the consensus splice site. In summary, the currently available evidence indicates that the variant is pathogenic, but additional data are needed to prove that conclusively. Therefore, this variant has been classified as Likely Pathogenic. - |
Retinal dystrophy Pathogenic:1
Likely pathogenic, criteria provided, single submitter | clinical testing | Blueprint Genetics | Jun 19, 2018 | - - |
CDHR1-related disorder Pathogenic:1
Likely pathogenic, criteria provided, single submitter | clinical testing | PreventionGenetics, part of Exact Sciences | May 03, 2023 | The CDHR1 c.55+1G>A variant is predicted to disrupt the GT donor site and interfere with normal splicing. To our knowledge, this variant has not been reported in the literature. This variant is reported in 0.13% of alleles in individuals of African descent in gnomAD (http://gnomad.broadinstitute.org/variant/10-85954572-G-A). Variants that disrupt the consensus splice donor site in CDHR1 are expected to be pathogenic. Therefore we interpret c.55+1G>A as likely pathogenic. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at